The global Venous Leg Ulcer (VLU) Treatment Market, which was valued at USD 4.07 billion in 2023, is anticipated to reach nearly USD 6.85 billion by 2031, reflecting a compound annual growth rate (CAGR) of 6.7% during the forecast period from 2024 to 2031. Key Players The major key players are, Integra Lifesciences, Smith & Nephew, Coloplast Corp, URGO, 3M, Paul Hartmann,...